| # | Drug | Count |
|---|---|---|
| 0 | LANSOPRAZOLE | 284 |
| 1 | OMEPRAZOLE MAGNESIUM | 255 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 195 |
| 3 | OMEPRAZOLE | 176 |
| 4 | FUROSEMIDE | 125 |
| 5 | PANTOPRAZOLE | 113 |
| 6 | ESOMEPRAZOLE | 90 |
| 7 | ASPIRIN | 89 |
| 8 | ASPIRIN 325 MG | 83 |
| 9 | ASPIRIN 81 MG | 83 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 3 | 0.0366 |
| 1 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 2 | 0.0364 |
| 2 | AMYL NITRITE | 1 | 0.0167 |
| 3 | DIMETHYL SULFOXIDE | 4 | 0.0165 |
| 4 | OMEPRAOLE, SODIUM BICARBONATE | 1 | 0.0031 |
| 5 | BASILIXIMAB | 26 | 0.0022 |
| 6 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 18 | 0.0022 |
| 8 | OMEPRAZOLE AND SODIUM BICARBONATE | 6 | 0.0021 |
| 9 | MINERAL OIL | 3 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Proton Pump Inhibitor [EPC] | 337 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 156 |
| 2 | Loop Diuretic [EPC] | 127 |
| 3 | Corticosteroid [EPC] | 117 |
| 4 | Benzodiazepine [EPC] | 109 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 89 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 85 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 76 |
| 8 | beta-Adrenergic Blocker [EPC] | 60 |
| 9 | Calcium Channel Blocker [EPC] | 58 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 7 | 0.0010 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 3 | Vitamin D2 Analog [EPC] | 5 | 0.0007 |
| 4 | Calcitonin [EPC] | 2 | 0.0006 |
| 5 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 6 | Chloride Channel Activator [EPC] | 6 | 0.0006 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 8 | Cannabinoid [EPC] | 5 | 0.0006 |
| 9 | Proton Pump Inhibitor [EPC] | 337 | 0.0006 |